Genflow Biosciences plc's latest marketcap:
As of 08/05/2025, Genflow Biosciences plc's market capitalization has reached $3.77 M. According to our data, Genflow Biosciences plc is the 44976th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.77 M |
| Revenue (ttm) | 795,035.71 |
| Net Income (ttm) | -2,110,070.21 |
| Shares Out | 453.55 M |
| EPS (ttm) | -0.01 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/26/2025 |
Genflow Biosciences plc's yearly market capitalization.
| Date | Market Cap(£) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/05/2025 | £2.83 M | $3.77 M | -53.01% | 44976 |
| 12/31/2024 | £6.03 M | $7.55 M | 44.72% | 39280 |
| 12/29/2023 | £4.17 M | $5.31 M | -40.63% | 39468 |
| 12/30/2022 | £7.02 M | $8.49 M | 36544 |
Company Profile
About Genflow Biosciences plc
Genflow Biosciences plc is a biotechnology company dedicated to developing innovative biological interventions to combat the effects of ageing. The company focuses on slowing, halting the ageing process, and reducing age-related diseases to enhance health span.
Key Products & Research
- GF-1002: A lead compound consisting of an adeno-associated viral vector-based gene therapy for intravenous infusion.
- GF-3001: A topical SIRT6 delivery system designed for skin applications.
- GF-4001: A veterinary anti-ageing pipeline for non-human use.
Company Overview
Founded in 2021, Genflow Biosciences plc operates primarily in the United Kingdom and Belgium, with its headquarters located in London.
Frequently Asked Questions
-
What is Genflow Biosciences plc's (LON-GENF) current market cap?As of 08/05/2025, Genflow Biosciences plc (including the parent company, if applicable) has an estimated market capitalization of $3.77 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Genflow Biosciences plc (LON-GENF) rank globally by market cap?Genflow Biosciences plc global market capitalization ranking is approximately 44976 as of 08/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.